CAPE CANAVERAL, Fla.--(BUSINESS WIRE)--Maxxsure, LLC, an independent cyber risk assessment, scoring and insurance company providing a quantitative framework-based solution that builds detailed assessments and quantification of processes, hardware/software and network vulnerabilities, has entered into a strategic partnership with SAFE-BioPharma Association, LLC, which manages the global SAFE-BioPharma® digital identity and signature standards.
Maxxsure plans to incorporate the SAFE-BioPharma requirements into its M-Score™ cyber risk assessment and scoring platform, allowing member companies to continuously evaluate their compliance relative to the SAFE-BioPharma identity trust standards. Organizations deploying M-Score™ will receive a quantified score that rates their overall cyber risk, including the effectiveness of the company’s cyber management, cyber risk exposure and supply chain management.
“Compliance and risk management are very high priorities for companies in the healthcare and biopharmaceutical industries. With continued use of the SAFE-BioPharma standards in these industries, incorporating them was the next step in ensuring that the M-Score platform continues to offer a comprehensive assessment,” says Srik Soogoor, President of Maxxsure, LLC.
“Adding SAFE-BioPharma requirements into the M-Score platform, will help organizations assess their exposure to risk related to identity management,” said Matt King, Director, SAFE-BioPharma Association, LLC.
In use since 2005, the SAFE-BioPharma Standard comprises a broad spectrum of requirements for standardized identity trust for authentication (the process that proves the user's identity to a computer system) and for digital signatures (the strongest form of electronic signature in existence). Among the many advantages of identity credentials compliant with the Standard is the use of a single, trusted cyber identity that can be recognized across all participating ecosystems.
About SAFE-BioPharma Association, LLC
As part of National Health Information Sharing and Analysis Center (NH-ISAC), SAFE-BioPharma Association, LLC provides global, high-assurance identity trust for cyber-transactions in the biopharmaceutical and healthcare industries.
The SAFE-BioPharma® digital identity and signature standards were crafted to mitigate risk associated with electronic transactions by protecting intellectual property and patient data using secure, enforceable, and regulatory compliant mechanisms.
SAFE-BioPharma® is a trademark of SAFE-BioPharma Association, LLC. Use of this trademark requires approval from SAFE-BioPharma Association, LLC.